The 20 years experience of TheraSphere™ Y-90 Therapy redefined the lives of 30,000 liver cancer patients in Europe.
Because life matters…
Backed by two decades of robust clinical evidence, TheraSphere™ is the only therapy proven to downstage HCC*, expanding curative options and improving overall survival for liver cancer patients.
Redefining liver cancer care for 20 years and beyond
Our symposium at ECIO 2025 moderated by Prof. Guiu and featuring expert insights from Prof. Salem, Prof. Garin, and Dr. Bhoori highlighted the evolution of SIRT in liver cancer management and how personalised dosimetry continues to drive better patient outcomes, expanding curative options.
Missed our live symposium? No worries! Catch the full event on demand right below.

Prof. Boris Guiu
Moderator
Interventional Radiologist, France
Prof. Riad Salem
Interventional Radiologist, USA
Prof. Etienne Garin
Nuclear Medicine Physician, France
Dr. Sherrie Bhoori
Hepatologist, Italy
Redefining liver cancer care
Learn more about the past, present, and future of TheraSphereTM Y-90 therapy and the key clinical milestones that have led the way in the last 20 years.
Your choice matters
Experience matters
For over 20 years, we have been investing in scientific evidence for TheraSphere™ Y-90 Therapy, proving efficacy throughout HCC treatment pathway. Today, 40 ongoing trials.

Power matters
TheraSphere™ glass microspheres deliver an unparalleled 4,000 Bq per sphere, a specifically engineered power to effectively treat all liver cancer tumours.

Safety matters
TheraSphere™ preserves healthy tissues while safely maximising tumour dose and minimising embolic load.

Precision matters
TheraSphere™ with personalised dosimetry ensures precise treatment planning for accurate, predictable and reproducible clinical outcomes.


SIRT Portfolio
Dive into our personalised dosimetry solutions and uncover TheraSphere™ Y-90 Therapy, the only SIRT (Selective Internal Radiation Therapy) backed by 20 years of proven experience.
Caution:
The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.
*Hepatocellular Carcinoma